PharmEnable
PharmEnable has developed a rapid and cost effective way to identify better chemical starting points to drive the discovery.
PharmEnable has raised €9.0M across 2 funding rounds from 9 investors, most recently a Seed round in May 2023. Based in Cambridge, UK; active in Healthtech. Data as of 28 Oct 2026.
Cambridge, UKwww.pharmenable.com ↗
Total raised
€9.0M
€9,021,085
Funding rounds
2
Investors
9
distinct backers
Active since
2020-01
latest 2023-05
Funding by year
EUR raised per yearPharmEnable — funding by year — interactive chart.
Data table
| PharmEnable — funding by year | |
|---|---|
| 2020 | €2.1M |
| 2023 | €6.9M |
Signals
High confidenceRaise-next likelihood9
base rate 44% for Seed
- ▼ Past typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood8
base rate 11% (2+ rounds)
- ▲ 6y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-05-22 | Seed | €6.9M | Arrowfield Capital,Cambridge Enterprise,Heyford Trust,Jonathan Milner,Martlet Capital,MP Healthcare Venture Management+2 more | View deal → |
| 2020-01-07 | Seed | €2.1M | Cambridge Enterprise,University of Cambridge Enterprise | View deal → |